These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2575243)
1. [Functional growth retardation and its correction]. Kiseleva EV Pediatriia; 1989; (11):98-9. PubMed ID: 2575243 [No Abstract] [Full Text] [Related]
2. [Disintoxication therapy of patients with nonspecific inflammatory diseases of the female genital organs]. Rzheusskaia LD Akush Ginekol (Mosk); 1977 Apr; (4):30-4. PubMed ID: 883594 [No Abstract] [Full Text] [Related]
3. [The drug arginine aspartate (pargin) in the therapy of hyposomal states]. Kiseleva EV; Zarubina NA; Pankova SS; Starkova NT Probl Endokrinol (Mosk); 1991; 37(3):28-9. PubMed ID: 1946288 [TBL] [Abstract][Full Text] [Related]
4. [Effect of arginine aspartate on height and weight deficit in children]. Mariggiò A Minerva Pediatr; 1979 Oct; 31(20):1489. PubMed ID: 537614 [No Abstract] [Full Text] [Related]
5. [Use of retabolil and thyrocalcitonin in patients with diaphyseal fractures of the extremities]. Alekseeva IM Ortop Travmatol Protez; 1980 Dec; (12):57-8. PubMed ID: 7219980 [No Abstract] [Full Text] [Related]
6. [Do anabolic steroids protect bone marrow during cytostatic therapy?]. Kopera H Med Klin; 1980 Jul; 75(15):539-43. PubMed ID: 7001201 [No Abstract] [Full Text] [Related]
7. [Anabolic steroids and growth]. Bierich JR Munch Med Wochenschr; 1971 Jun; 113(25):942-8. PubMed ID: 4996666 [No Abstract] [Full Text] [Related]
8. [Glutamic and aspartic acid in complex treatment of circulatory hypoxia]. Baskovich GA; Bondina VA; Kochetygov NI; Chaplygina ZA Patol Fiziol Eksp Ter; 1978; (1):20-5. PubMed ID: 643326 [No Abstract] [Full Text] [Related]
9. [Use of anabolic steroid retabolil in patients with inflammatory diseases of the uterus and its appendages]. Nazarov VG Ross Med Zh; 1992; (3):47-8. PubMed ID: 1643363 [No Abstract] [Full Text] [Related]
10. [Effect of retabolil on the functional activity of thyroid hormones of athletes]. Smirnova LK; Semenov VA; Seĭfulla RD; Kutepova OA; Mansvetova EV Farmakol Toksikol; 1983; 46(3):82-4. PubMed ID: 6861994 [No Abstract] [Full Text] [Related]
11. Two new antisickling agents and the use of amino acid salts. Sophianopoulos AJ; Sophianopoulos JA; Grush OC; Wilson JS; Fales FW Clin Biochem; 1974 Jun; 7(2):112-8. PubMed ID: 4210302 [No Abstract] [Full Text] [Related]
12. Paraffinoma and ulcer of the external genitalia after self-injection of nandrolone. Balighi K; Farsinejad K; Naraghi ZS; Tamizifar B Int J Dermatol; 2008 Oct; 47(10):1092-4. PubMed ID: 18986371 [No Abstract] [Full Text] [Related]
13. Effect of nandrolone phenpropionate on myelopoiesis. Kahn SB; Conroy JF; Brodsky I J Med; 1974; 5(6):303-9. PubMed ID: 4528544 [No Abstract] [Full Text] [Related]
14. [Klostilbegit in the functional retardation of the physical and sexual development of adolescent males]. Zarubina NA; Nekrasova LV; Dobracheva AD Sov Med; 1988; (3):111-3. PubMed ID: 3137662 [No Abstract] [Full Text] [Related]
15. Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardio-toxicity in an animal-model study. Fineschi V Acta Physiol (Oxf); 2013 Jun; 208(2):141-3. PubMed ID: 23480556 [No Abstract] [Full Text] [Related]
16. Higher physiological doses of nandrolone decanoate do not influence the Bezold-Jarish reflex control of bradycardia. Andrade TU; Santos MC; Busato VC; Medeiros AR; Abreu GR; Moysés MR; Bissoli NS Arch Med Res; 2008 Jan; 39(1):27-32. PubMed ID: 18067992 [TBL] [Abstract][Full Text] [Related]
17. [Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency]. Sinitsyn SP Kardiologiia; 1985 Jul; 25(7):111-2. PubMed ID: 2414506 [No Abstract] [Full Text] [Related]
18. [Current views on the therapy of hepatic coma]. Ziegler K Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690 [No Abstract] [Full Text] [Related]
19. [Constitutional delay of growth and puberty]. Cavallo L; Acquafredda A; Zecchino C; Delvecchio M Minerva Pediatr; 2001 Oct; 53(5):423-5. PubMed ID: 11668263 [No Abstract] [Full Text] [Related]
20. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate. Erdtsieck RJ; Pols HA; van Kuijk C; Birkenhäger-Frenkel DH; Zeelenberg J; Kooy PP; Mulder P; Birkenhäger JC J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]